Earnings FeedTerminal

⌘K

Home/Filings/6-K/0001144204-10-000094

6-K//Foreign company update

XTL BIOPHARMACEUTICALS LTD 6-K

Accession 0001144204-10-000094

$XTLBCIK 0001023549other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 1:27 PM ET

Size

24.2 KB

Accession

0001144204-10-000094

Documents

1 file

6-K
v170396_6k.htmPrimary

Issuer

XTL BIOPHARMACEUTICALS LTD

CIK 0001023549

Entity typeother

IncorporatedIsrael

Related Parties

1

filerCIK 0001023549

Filing Metadata

Form type: 6-K
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 1:27 PM ET
Size: 24.2 KB

View on SEC.gov